Grifols, S.A.

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Earnings data Q4 2019

Earnings data Q1 2020

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q4 2021

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

LOS ANGELES, CA / ACCESSWIRE / August 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for violations of the securities laws.

The Schall Law Firm Has Launched An Inquiry Into Grifols SA For Potential Securities Violations And Stockholders Are Invited To Assist

A Bloomberg article suggests that Brookfield Asset Management is in discussions with banks to raise nearly $11 billion to fund the takeover of Spain-based Grifols (GRFS).

Why Grifols (GRFS) Stock Price Moved Up 7% on Wednesday

LOS ANGELES, CA / ACCESSWIRE / August 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for violations of the securities laws.

Grifols SA Is Being Investigated By The Schall Law Firm For Securities Fraud And Shareholders Are Encouraged To Help

Canadian fund Brookfield is in talks with banks to raise funds for its possible takeover bid for beleaguered Spanish drugmaker Grifols , two people familiar with the matter said on Wednesday.

Brookfield in talks with banks for funding Grifols' takeover bid, sources say

Brookfield Asset Management is reportedly seeking 9.5 billion euros ($10.6 billion) in debt financing for a potential take-private deal for Grifols SA GRFS, a Spanish pharmaceutical company.

Brookfield Negotiates Over $10B In Debt Financing For Acquisition Of Spanish Pharma Giant Grifols

LOS ANGELES, CA / ACCESSWIRE / August 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for violations of the securities laws.

The Schall Law Firm Invites Investors In Grifols SA To Reach Out About The Company's Possible Securities Law Violations

LOS ANGELES, CA / ACCESSWIRE / August 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for violations of the securities laws.

The Schall Law Firm Encourages Shareholders With Losses In Grifols SA To Contact The Firm About Potential Securities Law Violations

LOS ANGELES, CA / ACCESSWIRE / August 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for violations of the securities laws.

Investors Are Invited To Reach Out To The Schall Law Firm About Grifols SA's Potential Securities Law Violations

LOS ANGELES, CA / ACCESSWIRE / August 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for violations of the securities laws.

Shareholders Are Encouraged To Contact The Schall Law Firm About Grifols SA's Potential Securities Violations

LOS ANGELES, CA / ACCESSWIRE / August 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for violations of the securities laws.

Allegations Against Grifols SA Are Being Investigated By The Schall Law Firm And Investors Are Invited To Join

LOS ANGELES, CA / ACCESSWIRE / August 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for violations of the securities laws.

Grifols SA Is Being Investigated By The Schall Law Firm And Impacted Investors Are Encouraged To Join

LOS ANGELES, CA / ACCESSWIRE / August 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for violations of the securities laws.

Grifols SA Is Being Looked Into By The Schall Law Firm And We Urge Impacted Investors To Join

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for violations of the securities laws.

Grifols SA Is Under Investigation By The Schall Law Firm, Which Urges Impacted Investors To Engage In Dialogue

Grifols SA Is Being Investigated By The Schall Law Firm And Impacted Investors Are Encouraged To Begin Discussions

Grifols SA Is Being Investigated By The Schall Law Firm And Impacted Investors Are Encouraged To Start Conversations

LOS ANGELES, CA / ACCESSWIRE / August 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for violations of the securities laws.

Grifols SA Is Under The Schall Law Firm's Probe And Affected Investors Are Urged To Begin Conversations

LOS ANGELES, CA / ACCESSWIRE / August 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for violations of the securities laws.

Grifols SA Is Being Investigated By The Schall Law Firm And Impacted Investors Are Encouraged To Initiate Dialogue

Grifols SA Is Under Investigation By The Schall Law Firm, Which Urges Impacted Investors To Initiate Dialogue

LOS ANGELES, CA / ACCESSWIRE / August 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for violations of the securities laws.

Grifols SA Investigated By The Schall Law Firm Urges Impacted Investors To Engage In Dialogue

SAN FRANCISCO--(BUSINESS WIRE)--Hagens Berman urges investors in Grifols, S.A. American Depositary Shares (NASDAQ: GRFS) who suffered substantial losses to submit your losses now. Visit: www.hbsslaw.com/investor-fraud/grfs Contact the Firm Now: GRFS@hbsslaw.com 844-916-0895 Grifols S.A. (GRFS) Investigation: On July 30, 2024, shares of embattled Spanish pharmaceutical and chemical manufacturer Grifols S.A. significantly declined during intraday trading after the company admitted to improper acc.

Grifols S.A. (GRFS) Admits Improper Accounting, Announces Restatements, Shares Decline Again – Hagens Berman

Spanish pharmaceutical company Grifols said on Tuesday it had revised its financial records between 2020 and 2023 lower by 457 million euros ($494 million) to adjust the value of its stake in Chinese company Shanghai RAAS.

Grifols revises past financial records with equity value drop of $494 mln

BARCELONA, Spain, July 29, 2024 (GLOBE NEWSWIRE) -- Grifols (MCE: GRF, MCE: GRF.P NASDAQ: GRFS), one of the world's leading producers of plasma-derived medicines, today announced that the United States Food and Drug Administration (FDA) has approved an expanded label for XEMBIFY®, the company's 20% subcutaneous immunoglobulin (SCIg), to include treatment-naïve patients with primary humoral immunodeficiencies (PI).

Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for patients

LOS ANGELES, CA / ACCESSWIRE / July 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for violations of the securities laws.

Grifols SA Under Investigation By The Schall Law Firm Encourages Impacted Investors To Initiate Dialogue

LOS ANGELES, CA / ACCESSWIRE / July 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for violations of the securities laws.

Grifols SA Is Under Investigation By The Schall Law Firm And Affected Investors Are Urged To Start Dialogue

Cigna

HubSpot

Spirit Airlines

Arvinas Inc

Flex Lng Ltd

CBRE Global Real Estate Income Fund

Inter & Co Inc

KKR Real Estate Finance Trust

Polestar Automotive Holding UK PLC

Rubrik Inc

We share 12 ideas published last week focused on stocks with less coverage on Seeking Alpha. Polestar Automotive Holding is seen as continuing to struggle with missed targets, high losses, and debt raises, warranting a sell. HubSpot faces volatility post-Google acquisition plans, while Grifols considers privatization amid debt concerns and shareholder issues.

News for Grifols, S.A. Stock (GRFS)